Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems

In recent decades, clustered regularly interspaced short palindromic repeat/CRISPR-associated protein (CRISPR/Cas) has become one of the most promising genome-editing tools for therapeutic purposes in biomedical and medical applications. Although the CRISPR/Cas system has truly revolutionized the er...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Faranak Hejabi, Mohammad Sadegh Abbaszadeh, Shirinsadat Taji, Andrew O’Neill, Fatemeh Farjadian, Mohammad Doroudian
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-07-01
Edice:	Frontiers in Chemistry
Témata:	nanocarriers CRISPR/Cas9 gene therapy nanomedicine non-viral vector
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fchem.2022.957572/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!